Dysplasia epiphysealis hemimelica
Asymmetrical cartilaginous overgrowth of one or more EPIPHYSES of primarily TARSAL BONES or CARPAL BONES, although it may occur in other bones. Males are affected about 3 times more often than females. The disorder appears to have no simple mendelian basis. No familial case has been reported. OMIM: 127800
Also Known As:
Trevor disease
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Disease Context: Research Results
Related Diseases
Experts
1. | Javid, Mahzad:
1 article
(07/2017)
|
2. | Shahcheraghi, Gholam Hossain:
1 article
(07/2017)
|
3. | Braman, Jonathan P:
1 article
(12/2011)
|
4. | Stewart, Thomas M:
1 article
(12/2011)
|
5. | Choi, J J:
1 article
(09/2000)
|
6. | Flemming, D J:
1 article
(09/2000)
|
7. | Gannon, F H:
1 article
(09/2000)
|
8. | Kransdorf, M J:
1 article
(09/2000)
|
9. | Murphey, M D:
1 article
(09/2000)
|
10. | Ishikawa, A:
1 article
(01/2000)
|
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Dysplasia epiphysealis hemimelica:
1. | GadoliniumIBA
01/01/1992
- " Sonographic applications to osteomyelitis, myositis ossificans, tropic pyomyositis, child abuse, synovitis, and slipped capital femoral epiphyses; MR imaging (including gadolinium-enhanced MR scans) in osteomyelitis, the normal and abnormal physis, physeal bars, normal marrow, Gaucher disease, cancer, dysplasia epiphysealis hemimelica, myositis, tenosynovitis, arthritis, and clubfoot; nuclear imaging in osteomyelitis, tibia valga, limp, and unexplained lower extremity pain; and CT in osteomyelitis, are reviewed. "
|
|
Therapies and Procedures